Top

Published in:

01-07-2010 | Review article

Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature

Authors: Sarah Nechuta, Nigel Paneth, Ellen M. Velie

Published in: Cancer Causes & Control | Issue 7/2010

Abstract

The short- and long-term effects of pregnancy on breast cancer risk are well documented. Insight into potential biological mechanisms for these associations may be gained by studying breast cancer risk and pregnancy characteristics (e.g., preeclampsia, twining), which may reflect hormone levels during pregnancy. To date, no review has synthesized the published literature for pregnancy characteristics and maternal breast cancer using systematic search methods. We conducted a systematic search to identify all published studies. Using PUBMED (to 31 July 2009), 42 relevant articles were identified. Several studies suggest that multiple births may be associated with a lowered breast cancer risk of about 10–30%, but results were inconsistent across 18 studies. The majority of 13 studies suggest about a 20–30% reduction in risk with preeclampsia and/or gestational hypertension. Six of seven studies reported no association for infant sex and breast cancer risk. Data are sparse and conflicting for other pregnancy characteristics such as gestational age, fetal growth, pregnancy weight gain, gestational diabetes, and placental abnormalities. The most consistent findings in a generally sparse literature are that multiple births and preeclampsia may modestly reduce breast cancer risk. Additional research is needed to elucidate associations between pregnancy characteristics, related hormonal profiles, and breast cancer risk.

Available only for authorised users

Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47PubMed

Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7:131–142PubMedCrossRef

MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221PubMed

Lane-Claypon J (1926) A further report on cancer of the breast, with special reference to its associated antecedent conditions. Reports on public health and medical subjects no. 32. Ministry of Health. His Majesty’s Stationary Office, London

Hsieh C, Pavia M, Lambe M et al (1994) Dual effect of parity on breast cancer risk. Eur J Cancer 30A:969–973PubMedCrossRef

Liu Q, Wuu J, Lambe M et al (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13:299–305PubMedCrossRef

Bruzzi P, Negri E, La Vecchia C et al (1988) Short term increase in risk of breast cancer after full term pregnancy. BMJ 297:1096–1098PubMedCrossRef

Lambe M, Hsieh C, Trichopoulos D et al (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9PubMedCrossRef

Albrektsen G, Heuch I, Kvale G (1995) The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 72:480–484PubMed

10.

Janerich DT, Hoff MB (1982) Evidence for a crossover in breast cancer risk factors. Am J Epidemiol 116:737–742PubMed

11.

Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6:281–291PubMedCrossRef

12.

Sivaraman L, Medina D (2002) Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 7:77–92PubMedCrossRef

13.

Russo J, Russo IH (1994) Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3:353–364PubMed

14.

Hoover RN, Troisi RJ (2001) Understanding mechanisms of breast cancer prevention. J Natl Cancer Inst 93:1119–1120PubMedCrossRef

15.

Cnattingius S, Torrang A, Ekbom A et al (2005) Pregnancy characteristics and maternal risk of breast cancer. JAMA 294:2474–2480PubMedCrossRef

16.

Innes KE, Byers TE (2004) First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 112:306–311PubMedCrossRef

17.

Troisi R, Weiss HA, Hoover RN et al (1998) Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9:641–647PubMedCrossRef

18.

Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A (2000) Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology 11:315–319PubMedCrossRef

19.

Wuu J, Hellerstein S, Lipworth L et al (2002) Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev 11:283–293PubMedCrossRef

20.

Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D (1990) Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1:247–250PubMedCrossRef

21.

Tamimi R, Lagiou P, Vatten LJ et al (2003) Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev 12:647–650PubMed

22.

Troisi R, Potischman N, Roberts JM et al (2003) Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 32:455–460PubMedCrossRef

23.

Atamer Y, Erden AC, Demir B, Kocyigit Y, Atamer A (2004) The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women. Acta Obstet Gynecol Scand 83:425–430PubMed

24.

Baksu A, Gurarslan H, Goker N (2004) Androgen levels in pre-eclamptic pregnant women. Int J Gynaecol Obstet 84:247–248PubMedCrossRef

25.

Barnabei VM, Krantz DA, Macri JN, Larsen JW Jr (1995) Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP. Prenat Diagn 15:1131–1134PubMedCrossRef

26.

Wald N, Cuckle H, Wu TS, George L (1991) Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down’s syndrome. Br J Obstet Gynaecol 98:905–908PubMed

27.

Hubinette A, Lichtenstein P, Brismar K et al (2003) Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 82:1004–1009PubMed

28.

Bartha JL, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R (2002) Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol 187:735–740PubMedCrossRef

29.

Polednak AP, Janerich DT (1983) Characteristics of first pregnancy in relation to early breast cancer. A case–control study. J Reprod Med 28:314–318PubMed

30.

Wohlfahrt J, Melbye M (1999) Maternal risk of breast cancer and birth characteristics of offspring by time since birth. Epidemiology 10:441–444PubMedCrossRef

31.

Innes KE, Byers TE (1999) Preeclampsia and breast cancer risk. Epidemiology 10:722–732PubMedCrossRef

32.

Titus-Ernstoff L, Hatch EE, Hoover RN et al (2001) Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 84:126–133PubMedCrossRef

33.

Wald NJ, Densem JW (1994) Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down’s syndrome. Prenat Diagn 14:717–719PubMedCrossRef

34.

Batra S, Sjoberg NO, Aberg A (1978) Human placental lactogen, estradiol-17beta, and progesterone levels in the third trimester and their respective values for detecting twin pregnancy. Am J Obstet Gynecol 131:69–72PubMed

35.

Masse J, Forest JC, Moutquin JM et al (1993) A prospective study of several potential biologic markers for early prediction of the development of preeclampsia. Am J Obstet Gynecol 169:501–508PubMed

36.

Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G (2006) Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 126:16–19PubMedCrossRef

37.

Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG (1999) Androgens in preeclampsia. Am J Obstet Gynecol 180:60–63PubMedCrossRef

38.

Wald NJ, Morris JK (2001) Multiple marker second trimester serum screening for pre-eclampsia. J Med Screen 8:65–68PubMedCrossRef

39.

Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16:1700–1712PubMedCrossRef

40.

Velie EM, Nechuta S, Osuch JR (2006) Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women. Breast Dis 22:1–19

41.

Forman MR, Cantwell MM, Ronckers C, Zhang Y (2005) Through the looking glass at early-life exposures and breast cancer risk. Cancer Invest 23:609–624PubMedCrossRef

42.

ISI Web of Knowledge: http://www.isiwebofknowledge.com/

43.

Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ (1986) Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer 37:21–25PubMedCrossRef

44.

Clavel-Chapelon F, Launoy G, Auquier A et al (1995) Reproductive factors and breast cancer risk. Effect of age at diagnosis. Ann Epidemiol 5:315–320PubMedCrossRef

45.

Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88:756–758PubMedCrossRef

46.

Talamini R, Franceschi S, Favero A et al (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699–1703PubMed

47.

La Vecchia C, Negri E, Braga C, Fanceschi S (1996) Multiple births and breast cancer. Int J Cancer 68:553–554PubMedCrossRef

48.

Hsieh CC, Goldman M, Pavia M et al (1993) Breast cancer risk in mothers of multiple births. Int J Cancer 54:81–84PubMedCrossRef

49.

Thomas HV, Murphy MF, Key TJ et al (1998) Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol 25:69–75PubMedCrossRef

50.

Bortolus R, Parazzini F, Chatenoud L et al (1999) The epidemiology of multiple births. Hum Reprod Update 5:179–187PubMedCrossRef

51.

Blondel B, Kaminski M (2002) Trends in the occurrence, determinants, and consequences of multiple births. Semin Perinatol 26:239–249PubMedCrossRef

52.

Endres L, Wilkins I (2005) Epidemiology and biology of multiple gestations. Clin Perinatol 32:301–314PubMedCrossRef

53.

Wyshak G, Honeyman MS, Flannery JT, Beck AS (1983) Cancer in mothers of dizygotic twins. J Natl Cancer Inst 70:593–599PubMed

54.

Albrektsen G, Heuch I, Kvale G (1995) Multiple births, sex of children and subsequent breast-cancer risk for the mothers: a prospective study in Norway. Int J Cancer 60:341–344PubMed

55.

Mogren I, Stenlund H, Hogberg U (2001) Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 40:849–854PubMedCrossRef

56.

Neale RE, Purdie DM, Murphy MF et al (2004) Twinning and the incidence of breast and gynecological cancers (United States). Cancer Causes Control 15:829–835PubMedCrossRef

57.

Neale RE, Darlington S, Murphy MF et al (2005) The effects of twins, parity and age at first birth on cancer risk in Swedish women. Twin Res Hum Genet 8:156–162PubMedCrossRef

58.

Murphy MF, Broeders MJ, Carpenter LM, Gunnarskog J, Leon DA (1997) Breast cancer risk in mothers of twins. Br J Cancer 75:1066–1068PubMed

59.

Lambe M, Hsieh C, Tsaih S et al (1996) Maternal risk of breast cancer following multiple births: a nationwide study in Sweden. Cancer Causes Control 7:533–538PubMedCrossRef

60.

Ji J, Forsti A, Sundquist J, Hemminki K (2007) Risks of breast, endometrial, and ovarian cancers after twin births. Endocr Relat Cancer 14:703–711PubMedCrossRef

61.

Jacobson HI, Thompson WD, Janerich DT (1989) Multiple births and maternal risk of breast cancer. Am J Epidemiol 129:865–873PubMed

62.

Nasca PC, Weinstein A, Baptiste M, Mahoney M (1992) The relation between multiple births and maternal risk of breast cancer. Am J Epidemiol 136:1316–1320PubMed

63.

Dietz AT, Newcomb PA, Storer BE, Longnecker MP, Mittendorf R (1995) Multiple births and risk of breast cancer. Int J Cancer 62:162–164PubMedCrossRef

64.

Olsen J, Storm H (1998) Pregnancy experience in women who later developed oestrogen-related cancers (Denmark). Cancer Causes Control 9:653–657PubMedCrossRef

65.

Lichtenstein P, Olausson PO, Kallen AJ (1996) Twin births to mothers who are twins: a registry based study. BMJ 312:879–881PubMed

66.

Trapp M, Kato K, Bohnet HG et al (1986) Human placental lactogen and unconjugated estriol concentrations in twin pregnancy: monitoring of fetal development in intrauterine growth retardation and single intrauterine fetal death. Am J Obstet Gynecol 155:1027–1031PubMed

67.

Johnson JM, Harman CR, Evans JA, MacDonald K, Manning FA (1990) Maternal serum alpha-fetoprotein in twin pregnancy. Am J Obstet Gynecol 162:1020–1025PubMed

68.

Bennett JA, Zhu S, Pagano-Mirarchi A, Kellom TA, Jacobson HI (1998) Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. Clin Cancer Res 4:2877–2884PubMed

69.

Jacobson HI, Lemanski N, Narendran A et al (2008) Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk. Adv Exp Med Biol 617:477–484PubMedCrossRef

70.

Roberts JM, Pearson G, Cutler J, Lindheimer M (2003) Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41:437–445PubMedCrossRef

71.

Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594PubMedCrossRef

72.

Mutter WP, Karumanchi SA (2008) Molecular mechanisms of preeclampsia. Microvasc Res 75:1–8PubMedCrossRef

73.

Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565PubMedCrossRef

74.

Schrocksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O (1993) Tumor markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest 35:204–208PubMedCrossRef

75.

Raty R, Koskinen P, Alanen A et al (1999) Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 19:122–127PubMedCrossRef

76.

Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB (1996) The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 88:816–822PubMedCrossRef

77.

Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87:971–973PubMedCrossRef

78.

Vatten LJ, Forman MR, Nilsen TI, Barrett JC, Romundstad PR (2007) The negative association between pre-eclampsia and breast cancer risk may depend on the offspring’s gender. Br J Cancer 96:1436–1438PubMed

79.

Calderon-Margalit R, Friedlander Y, Yanetz R et al (2009) Preeclampsia and subsequent risk of cancer: update from the Jerusalem perinatal study. Am J Obstet Gynecol 200:63.e1–63.e5CrossRef

80.

Richardson BE, Peck JD, Wormuth JK (2000) Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 9:1349–1355PubMed

81.

Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK (2001) Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 93:1133–1140PubMedCrossRef

82.

Paltiel O, Friedlander Y, Tiram E et al (2004) Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 328:919PubMedCrossRef

83.

Terry MB, Perrin M, Salafia CM et al (2007) Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 165:1007–1014PubMedCrossRef

84.

Thompson WD, Jacobson HI, Negrini B, Janerich DT (1989) Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 81:1571–1574PubMedCrossRef

85.

Troisi R, Innes KE, Roberts JM, Hoover RN (2007) Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role? Br J Cancer 97:688–690PubMedCrossRef

86.

Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213–218PubMedCrossRef

87.

Ranta T, Stenman UH, Unnerus HA, Rossi J, Seppala M (1980) Maternal plasma prolactin levels in preeclampsia. Obstet Gynecol 55:428–430PubMed

88.

Rosing U, Carlstrom K (1984) Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest 18:199–205PubMedCrossRef

89.

Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA (2000) Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 182:589–594PubMedCrossRef

90.

Troisi R, Vatten L, Hoover RN et al (2006) Maternal androgen and estrogen concentrations are not associated with blood pressure changes in uncomplicated pregnancies. Cancer Epidemiol Biomarkers Prev 15:2013–2015PubMedCrossRef

91.

Grobman WA, Kazer RR (2001) Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol 97:521–526PubMedCrossRef

92.

Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S (2004) Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 84:214–219PubMedCrossRef

93.

Kocyigit Y, Bayhan G, Atamer A, Atamer Y (2004) Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 18:341–348PubMedCrossRef

94.

Ning Y, Williams MA, Vadachkoria S et al (2004) Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem 37:968–973PubMedCrossRef

95.

Vatten LJ, Nilsen TI, Juul A et al (2008) Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol 158:101–105PubMedCrossRef

96.

Boudreau N, Myers C (2003) Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Res 5:140–146PubMedCrossRef

97.

Aagaard-Tillery KM, Stoddard GJ, Holmgren C et al (2006) Preeclampsia and subsequent risk of cancer in Utah. Am J Obstet Gynecol 195:691–699PubMedCrossRef

98.

Vatten LJ, Romundstad PR, Jenum PA, Eskild A (2009) Angiogenic balance in pregnancy and subsequent breast cancer risk and survival: a population study. Cancer Epidemiol Biomarkers Prev 18:2074–2078PubMedCrossRef

99.

Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683PubMedCrossRef

100.

Levine RJ, Lam C, Qian C et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992–1005PubMedCrossRef

101.

Obiekwe BC, Chard T (1982) Human chorionic gonadotropin levels in maternal blood in late pregnancy: relation to birthweight, sex and condition of the infant at birth. Br J Obstet Gynaecol 89:543–546PubMed

102.

Hsieh C, Wuu J, Trichopoulos D, Adami HO, Ekbom A (1999) Gender of offspring and maternal breast cancer risk. Int J Cancer 81:335–338PubMedCrossRef

103.

Wohlfahrt J, Melbye M (2000) Gender of offspring and long-term maternal breast cancer risk. Br J Cancer 82:1070–1072PubMedCrossRef

104.

Albrektsen G, Heuch I, Kvale G (2000) Does gender of offspring modify the time-related effects of a pregnancy on breast cancer risk? Int J Cancer 86:595–597PubMedCrossRef

105.

Chen RJ, Lin YH, Huang SC (1994) Fetal sex and maternal alpha-fetoprotein concentration at late normal singleton pregnancies. Acta Obstet Gynecol Scand 73:192–194PubMedCrossRef

106.

Bremme K, Eneroth P, Nilsson B, Marsk L, Hagenfeldt L (1988) Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up. Gynecol Obstet Invest 26:191–205PubMedCrossRef

107.

Lagiou P, Samoli E, Lagiou A et al (2007) Levels and correlates of alpha-fetoprotein in normal pregnancies among Caucasian and Chinese women. Eur J Cancer Prev 16:178–183PubMedCrossRef

108.

Wingo PA, Newsome K, Marks JS, Calle EE, Parker SL (1997) The risk of breast cancer following spontaneous or induced abortion. Cancer Causes Control 8:93–108PubMedCrossRef

109.

Beral V, Bull D, Doll R, Peto R, Reeves G (2004) Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 363:1007–1016PubMedCrossRef

110.

Lapillonne H, Golsteyn RM, Lapillonne A (1999) Duration of pregnancy and risk of breast cancer. Lancet 353:2075PubMedCrossRef

111.

Kramer MS (1987) Intrauterine growth and gestational duration determinants. Pediatrics 80:502–511PubMed

112.

Savitz DA, Dole N, Herring AH et al (2005) Should spontaneous and medically indicated preterm births be separated for studying aetiology? Paediatr Perinat Epidemiol 19:97–105PubMedCrossRef

113.

Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84PubMedCrossRef

114.

Melbye M, Wohlfahrt J, Andersen AM, Westergaard T, Andersen PK (1999) Preterm delivery and risk of breast cancer. Br J Cancer 80:609–613PubMedCrossRef

115.

Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Pregnancy related protection against breast cancer depends on length of gestation. Br J Cancer 87:289–290PubMedCrossRef

116.

Hsieh CC, Wuu J, Lambe M et al (1999) Delivery of premature newborns and maternal breast-cancer risk. Lancet 353:1239PubMedCrossRef

117.

David RJ (1980) The quality and completeness of birthweight and gestational age data in computerized birth files. Am J Public Health 70:964–973PubMedCrossRef

118.

Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M (1996) A United States national reference for fetal growth. Obstet Gynecol 87:163–168PubMedCrossRef

119.

Emery ES 3rd, Eaton A, Grether JK, Nelson KB (1997) Assessment of gestational age using birth certificate data compared with medical record data. Paediatr Perinat Epidemiol 11:313–321PubMedCrossRef

120.

Braunstein G (2003) Endocrine changes in pregnancy. In: Kronenberg H, Melmed S, Polonsky K, Reed Larsen P (eds) Williams textbook of endocrinology

121.

Campagnoli C, Abba C, Ambroggio S, Peris C (2005) Pregnancy, progesterone and progestins in relation to breast cancer risk. J Steroid Biochem Mol Biol 97:441–450PubMedCrossRef

122.

Mazor M, Hershkovitz R, Chaim W et al (1994) Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios. Am J Obstet Gynecol 171:231–236PubMed

123.

Troisi R, Potischman N, Roberts J et al (2003) Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 14:347–355PubMedCrossRef

124.

Peck JD, Hulka BS, Savitz DA et al (2003) Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol 157:258–266PubMedCrossRef

125.

Nagata C, Iwasa S, Shiraki M, Shimizu H (2006) Estrogen and alpha-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight. Cancer Epidemiol Biomarkers Prev 15:1469–1472PubMedCrossRef

126.

Kramer MS, McLean FH, Boyd ME, Usher RH (1988) The validity of gestational age estimation by menstrual dating in term, preterm, and postterm gestations. JAMA 260:3306–3308PubMedCrossRef

127.

Oken E, Kleinman KP, Rich-Edwards J, Gillman MW (2003) A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 3:6PubMedCrossRef

128.

Romo A, Carceller R, Tobajas J (2009) Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev 6(Suppl 3):332–336PubMed

129.

Mucci LA, Lagiou P, Tamimi RM et al (2003) Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control 14:311–318PubMedCrossRef

130.

Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35PubMed

131.

Boyne MS, Thame M, Bennett FI et al (2003) The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J Clin Endocrinol Metab 88:1687–1691PubMedCrossRef

132.

Chellakooty M, Vangsgaard K, Larsen T et al (2004) A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 89:384–391PubMedCrossRef

133.

Murphy VE, Smith R, Giles WB, Clifton VL (2006) Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27:141–169PubMedCrossRef

134.

Holmes R, Montemagno R, Jones J et al (1997) Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Hum Dev 49:7–17PubMedCrossRef

135.

Ballard-Barbash R (1994) Anthropometry and breast cancer. Body size—a moving target. Cancer 74:1090–1100PubMedCrossRef

136.

Kumar NB, Lyman GH, Allen K, Cox CE, Schapira DV (1995) Timing of weight gain and breast cancer risk. Cancer 76:243–249PubMedCrossRef

137.

Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10:15–32PubMedCrossRef

138.

Hilakivi-Clarke L, Luoto R, Huttunen T, Koskenvuo M (2005) Pregnancy weight gain and premenopausal breast cancer risk. J Reprod Med 50:811–816PubMed

139.

Kinnunen TI, Luoto R, Gissler M, Hemminki E, Hilakivi-Clarke L (2004) Pregnancy weight gain and breast cancer risk. BMC Womens Health 4:7PubMedCrossRef

140.

Han D, Nie J, Bonner MR et al (2006) Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study. Int J Cancer 119:2931–2937PubMedCrossRef

141.

Peterson NB, Huang Y, Newcomb PA et al (2008) Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:3284–3287PubMedCrossRef

142.

Rossner S, Ohlin A (1995) Pregnancy as a risk factor for obesity: lessons from the Stockholm pregnancy and weight development study. Obes Res 3(Suppl 2):267s–275sPubMed

143.

Linne Y, Dye L, Barkeling B, Rossner S (2004) Long-term weight development in women: a 15-year follow-up of the effects of pregnancy. Obes Res 12:1166–1178PubMedCrossRef

144.

Amorim AR, Rossner S, Neovius M, Lourenco PM, Linne Y (2007) Does excess pregnancy weight gain constitute a major risk for increasing long-term BMI? Obesity (Silver Spring) 15:1278–1286CrossRef

145.

Butte NF, Ellis KJ, Wong WW, Hopkinson JM, Smith EO (2003) Composition of gestational weight gain impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol 189:1423–1432PubMedCrossRef

146.

Petridou E, Katsouyanni K, Hsieh CC, Antsaklis A, Trichopoulos D (1992) Diet, pregnancy estrogens and their possible relevance to cancer risk in the offspring. Oncology 49:127–132PubMedCrossRef

147.

Kaijser M, Jacobsen G, Granath F, Cnattingius S, Ekbom A (2002) Maternal age, anthropometrics and pregnancy oestriol. Paediatr Perinat Epidemiol 16:149–153PubMedCrossRef

148.

Lagiou P, Lagiou A, Samoli E et al (2006) Diet during pregnancy and levels of maternal pregnancy hormones in relation to the risk of breast cancer in the offspring. Eur J Cancer Prev 15:20–26PubMedCrossRef

149.

Faupel-Badger JM, Hoover RN, Potischman N, Roberts JM, Troisi R (2008) Pregnancy weight gain is not associated with maternal or mixed umbilical cord estrogen and androgen concentrations. Cancer Causes Control

150.

(2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1): S62–S67

151.

Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRef

152.

Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862PubMedCrossRef

153.

Perrin MC, Terry MB, Kleinhaus K et al (2008) Gestational diabetes and the risk of breast cancer among women in the Jerusalem perinatal study. Breast Cancer Res Treat 108:129–135PubMedCrossRef

154.

Dawson SI (2004) Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100:149–155PubMedCrossRef

155.

Rollison DE, Giuliano AR, Sellers TA, et al. (2007) Population-based case–control study of diabetes and breast cancer risk in Hispanic and Non-Hispanic White women living in US southwestern states. Am J Epidemiol

156.

Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868PubMedCrossRef

157.

Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:s823–s835PubMed

158.

Ish-Shalom D, Christoffersen CT, Vorwerk P et al (1997) Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40:S25–S31PubMedCrossRef

159.

Chappell J, Leitner JW, Solomon S et al (2001) Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J Biol Chem 276:38023–38028PubMedCrossRef

160.

Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68–72PubMedCrossRef

161.

Niedowicz DM, Daleke DL (2005) The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43:289–330PubMedCrossRef

162.

Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267PubMedCrossRef

163.

Hsieh CC, Goldman M, Pavia M et al (1994) Re: “the relation between multiple births and maternal risk of breast cancer” and “multiple births and maternal risk of breast cancer”. Am J Epidemiol 139:445–447PubMed

Title: Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature
Authors: Sarah Nechuta
Nigel Paneth
Ellen M. Velie
Publication date: 01-07-2010
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 7/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-010-9524-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2010

Family history and lung cancer risk: international multicentre case–control study in Eastern and Central Europe and meta-analyses

Head injury, diagnostic X-rays, and risk of medulloblastoma and primitive neuroectodermal tumor: a Children’s Oncology Group study

Meeting the cervical cancer screening needs of underserved women: The National Breast and Cervical Cancer Early Detection Program, 2004–2006

Case–control study of lifetime total physical activity and endometrial cancer risk

Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population

A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer